Factores inmunológicos relacionados con VIH-1 en pacientes colombianos
Barra lateral del artículo
Contenido principal del artículo
Descargas
Damariz Marin-Palma, MSc, Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Universidad Cooperativa de Colombia, Medellín.
Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Universidad Cooperativa de Colombia, Medellín.Jaiberth A. Cardona-Arias, MSc, Escuela de Microbiología, Universidad de Antioquia, Universidad Cooperativa de Colombia, Medellín.
Escuela de Microbiología, Universidad de Antioquia, Universidad Cooperativa de Colombia, Medellín.Juan Carlos Hernández, Sci Doc, Universidad Cooperativa de Colombia, Medellín.
Universidad Cooperativa de Colombia, Medellín.Im H, Ammit AJ. The NLRP3 inflammasome: role in airway inflammation. Clin Exp Allergy. 2014;44(2):160-72. Doi: 10.1111/cea.12206
Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nature reviews Immunology. 2016;16(7):407-20. Doi: 10.1038/nri.2016.58
McIntire CR, Yeretssian G, Saleh M. Inflammasomes in infection and inflammation. Apoptosis: an international journal on programmed cell death. 2009;14(4):522-35. Doi: 10.1007/s10495-009-0312-3
Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, et al. Association of mutations in the nalp3/cias1/pypaf1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis and rheumatism. 2002;46(9):2445-52. Doi: 10.1002/art.10509
Hernandez JC, Latz E, Urcuqui-Inchima S. hiv-1 induces the first signal to activate the NLRP3 inflammasome in monocyte-derived macrophages. Intervirology. 2014;57(1):36-42. Doi: 10.1159/000353902
Boasso A, Shearer GM. Chronic innate immune activation as a cause of hiv-1 immunopathogenesis. Clinical immunology. 2008;126(3):235-42. Doi: 10.1016/j. clim.2007.08.015
Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, et al. Persistent immune activation in hiv-1 infection is associated with progression to aids. Aids. 2003;17(13):1881-8. Doi: 10.1097/01.aids.0000076311.76477.6e
Neuhaus J, Jacobs DR, Jr., Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with hiv infection. The Journal of infectious diseases. 2010;201(12):1788-95. Doi: 10.1086/652749
Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR. Interleukin 1 induces hiv-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Molecular medicine. 1995;1(6):667-77. Doi: 10.1007/BF03401607
Shapiro L, Puren AJ, Barton HA, Novick D, Peskind RL, Shenkar R, et al. Interleukin 18 stimulates hiv type 1 in monocytic cells. Proc Natl Acad Sci U S A. 1998;95(21):12550-5. Doi: https://doi.org/10.1073/pnas.95.21.12550
Feria MG, Taborda NA, Hernández JC, Rugeles MT. hiv replication is associated to inflammasomes activation, il-1beta, il-18 and caspase-1 expression in galt and peripheral blood. PLoS One. 2018;13(4):e0192845. Doi: 10.1371/journal.pone.0192845
Marín-Palma D, Taborda N, Urcuqui-Inchima S, Hernández J. Inflamación y respuesta inmune innata: Participación de las lipoproteínas de alta densidad. IATREIA. 2017 OctDic;30(4):423-35. Doi: 10.17533/udea.iatreia.v30n4a06
Rangaswamy KS. Correlation between High-density Lipoprotein Cholesterol Level and cd4 Cell Count in hiv Patients on nnrti-Based art Regimen at Tertiary Care Hospital in Mysuru. Int J Sci Stud. 2017;5(3):150-4. Doi: 10.17354/ijss/2017/286
Marín-Palma D, Castro G, Cardona-Arias J, Urcuqui-Inchima S, Hernández J. Lower HighDensity Lipoproteins Levels During Human Immunodeficiency Virus Type I Infection Are Associated with Increased Inflammatory Markers and Disease Progression. Front Immunol. 2018;9:1350. Doi: 10.3389/fimmu.2018.01350
Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Medicine. 2008;5(10):e203. Doi: 10.1371/journal.pmed.0050203
Abraham AG, Darilay A, McKay H, Margolick JB, Estrella MM, Palella FJ, Jr., et al. Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study. The Journal of infectious diseases. 2015;212(7):1100-10. Doi: 10.1093/infdis/jiv159
Eckard AR, Rosebush JC, O’Riordan MA, Graves CC, Alexander A, Grover AK, et al. Neurocognitive dysfunction in hiv-infected youth: investigating the relationship with immune activation. Antiviral therapy. 2017;22(8):669-80. Doi: 10.3851/IMP3157
Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz D. Plasma interleukin-18 is associated with viral load and disease progression in hiv-1-infected patients. Microbes Infect. 2004;6(14):1273-7. Doi: 10.1016/j.micinf.2004.07.009
Thacker SG, Zarzour A, Chen Y, Alcicek MS, Freeman LA, Sviridov DO, et al. High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology. 2016;149(3):306-19. Doi: 10.1111/imm.12638
Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 2011;3(6):920-40. Doi: 10.3390/v3060920
Socias ME, Sued O, Laufer N, Lazaro ME, Mingrone H, Pryluka D, et al. Acute retroviral syndrome and high baseline viral load are predictors of rapid hiv progression among untreated Argentinean seroconverters. J Int AIDS Soc. 2011;14:40. Doi: 10.1186/17582652-14-40
Turk G, Ghiglione Y, Hormanstorfer M, Laufer N, Coloccini R, Salido J, et al. Biomarkers of Progression after hiv Acute/Early Infection: Nothing Compares to cd4(+) T-cell Count? Viruses. 2018;10(1). Doi: 10.3390/v10010034
Gunthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, et al. Antiretroviral Drugs for Treatment and Prevention of hiv Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. Jama. 2016;316(2):191-210. Doi: 10.1001/ jama.2016.8900
Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, et al. Adult antiretroviral therapy guidelines 2017. South Afr J hiv Med. 2017;18(1):776. Doi: 10.4102/ sajhivmed.v18i1.776
Lu W, Mehraj V, Vyboh K, Cao W, Li T, Routy JP. cd4:cd8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed hiv-positive patients. J Int aids Soc. 2015;18:20052. Doi: 10.7448/IAS.18.1.20052
Bastard JP, Soulie C, Fellahi S, Haim-Boukobza S, Simon A, Katlama C, et al. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled hiv-infected patients. Antiviral Therapy. 2012;17(5):915-9. Doi: 10.3851/IMP2093
Murday AS, Chaudhry S, Pauza CD. Interleukin-18 activates Vgamma9Vdelta2(+) T cells from hiv-positive individuals: recovering the response to phosphoantigen. Immunology. 2017;151(4):385-94. Doi: 10.1111/imm.12735
Detalles del artículo
Los manuscritos postulados a la Revista Ciencias de la Salud deben ser originales e inéditos y no deben estar simultáneamente en proceso de publicación en otras revistas, compilaciones o cualquier otro medio de publicación. Los derechos de autor serán de la Universidad del Rosario. Cuando el autor quiera publicar el manuscrito en otra publicación, deberá pedir a la Editorial de la Universidad del Rosario los permisos correspondientes. De igual forma, cuando la Revista Ciencias de la Salud esté interesada en publicar artículos que ya han sido publicados en otras revistas, procederá a solicitar los permisos correspondientes en la editorial donde se realizó la primera publicación.
Bajo una Creative Commons Attribution License los autores pueden compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista.